L36. Evidence-based clinical science and art in the diagnosis of central nervous system vasculitis

Presse Med. 2013 Apr;42(4 Pt 2):600-2. doi: 10.1016/j.lpm.2013.01.036. Epub 2013 Mar 6.

Author

Leonard H Calabrese¹

Affiliation

¹ Cleveland Clinic Lerner, College of Medicine of Case Western Reserve University, Department of Rheumatic and Immunologic Diseases, Cleveland, Ohio 44195, United States. calabrl@ccf.org

PMID: 23474051
DOI: 10.1016/j.lpm.2013.01.036

No abstract available

Publication types

Review

MeSH terms

Acute-Phase Proteins / analysis
Anti-Inflammatory Agents / therapeutic use
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis*
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / pathology
Antibodies, Antineutrophil Cytoplasmic / blood
Bayes Theorem
Biopsy
Brain / pathology
Cryoglobulins / analysis
Cyclophosphamide / therapeutic use
Diagnosis, Differential
Diagnostic Imaging
Evidence-Based Medicine*
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Predictive Value of Tests
Spinal Puncture
Treatment Failure
Vasculitis, Central Nervous System / diagnosis*
Vasculitis, Central Nervous System / drug therapy
Vasculitis, Central Nervous System / pathology

Substances

Acute-Phase Proteins
Anti-Inflammatory Agents
Antibodies, Antineutrophil Cytoplasmic
Cryoglobulins
Glucocorticoids
Immunosuppressive Agents
Cyclophosphamide

Supplementary concepts

Primary angiitis of the central nervous system